ESR1 and breast cancer: In ER+ breast cancer, which accounts for 70–80% of human breast cancer tumors (Sohail et al. 2020), HOTAIR is induced through estradiol (E2), the main form of estrogen, by binding to estrogen response elements (EREs) on its promoter region.